Concord Drugs Share Price
Know More₹53.29 2.14 (4.18%)
04:01 PM, 3-Jul-2025BSE : 538965
Sector : Health care
ISIN Code : INE858L01010
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 03-Jul-2025 | 09:31 PM IST
| Market Cap (₹ Cr.) | 53 |
Traded Value (₹ Cr) | 1.96 |
Volume (Shares) | 3,67,336 |
Face Value (₹) | 10 |
52-Week High (₹) | 53.95 |
52-Week High Date | 03-Jul-2025 |
52-Week Low (₹) | 26.10 |
52-Week Low Date | 03-Mar-2025 |
All Time High (₹) | 91.25 |
All Time High Date | 07-Apr-2015 |
All Time Low (₹) | 11.68 |
All Time Low Date | 26-Mar-2020 |
Concord Drugs Ltd
Market News
Concord Drugs Announcement
Concord Drugs Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr.) | 53 |
| EPS - TTM (₹) [C] | 0.34 |
| P/E Ratio (X) [C] | 156.74 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | - |
| Latest Dividend Date | - |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 34.11 |
| P/B Ratio (₹) [C] | 1.56 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Data Not Found | |||
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 51.48 53.95 |
| Week Low/High (₹) | 30.51 53.95 |
| Month Low/High (₹) | 29.00 53.95 |
| Year Low/High (₹) | 26.10 54.00 |
| All time Low/High (₹) | 11.68 91.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 70.75% | - | -0.62% | -0.56% |
| 1 Month | 67.32% | - | 3.10% | 3.52% |
| 3 Month | 67.11% | - | 9.10% | 9.27% |
| 6 Month | 38.56% | - | 5.07% | 5.83% |
| 1 Year | 34.67% | - | 4.07% | 4.61% |
| 3 Year | 105.75% | - | 57.33% | 61.28% |
Company Info
Company Information
Chairman & Managing Director : S Nagi Reddy
Independent Director : K Ramchandra Reddy
Whole Time Director & CFO : Koni Reddy
Independent Director : S. Nagavenkata Hareesh
Whole-time Director : S. Manoj Kumar Reddy
Independent Director : Summela Kasu
Company Sec. & Compli. Officer : Namratha Nagla
Registered Office: Survey No 249 Brahmanapally V, Hayathnagar M,Ranga Reddy,Telangana-501511 Ph: 91-40-24036379
FAQs about Concord Drugs Ltd
1. What's the Concord Drugs Ltd share price today?
Concord Drugs Ltd share price was Rs 53.29 at 04:01 PM IST on 3rd Jul 2025. Concord Drugs Ltd share price was up by 4.18% over the previous closing price of Rs 51.15. Concord Drugs Ltd share price trend:
- Last 1 Month: Concord Drugs Ltd share price moved up by 67.32% on BSE.
- Last 3 Months: Concord Drugs Ltd share price moved up by 67.11% on BSE.
- Last 12 Months: Concord Drugs Ltd share price moved up by 34.67% on BSE.
- Last 3 Years: Concord Drugs Ltd share price moved up by 105.75% on BSE.
2. How can I quickly analyse the performance of the Concord Drugs Ltd stock?
The performance of the Concord Drugs Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 156.74
- Price to book value ratio is 1.56
- The EPS (trailing 12 months) of the Concord Drugs Ltd stock is Rs 0.34
3. What is the market cap of Concord Drugs Ltd?
Concord Drugs Ltd has a market capitalisation of Rs 53 crore.
4. What is Concord Drugs Ltd's 52-week high/low share price?
The Concord Drugs Ltd’s 52-week high share price is Rs 53.95 and 52-week low share price is Rs 26.10.
5. Is the Concord Drugs Ltd profitable?
On a consolidated basis, Concord Drugs Ltd reported a profit of Rs 0.04 crore on a total income of Rs 10.40 crore for the quarter ended 2025. For the year ended 2024, Concord Drugs Ltd had posted a profit of Rs 0.47 crore on a total income of Rs 44.92 crore.
6. Which are Concord Drugs Ltd’s peers in the Health care sector?
Concord Drugs Ltd’s top 5 peers in the Health care sector are Vasundhara Rasy., Dipna Pharmachem, Lasa Supergeneri, Concord Drugs, Sandu Pharma., Shelter Pharma, Roopa Industries.
7. Who owns how much in Concord Drugs Ltd?
Key changes to the Concord Drugs Ltd shareholding are as follows:
- Promoter holding in Concord Drugs Ltd has gone down to 54.39 per cent as of Mar 2025 from 55.41 per cent as of Jun 2024.
